The increased levels of FMR1 mRNA has led to the RNA gain- of- function model in which the FMR1 mRNA itself is causative of the clinical problems observed in carriers, including FXTAS. The gene discussed is FMR1; the disease is fragile X-associated tremor/ataxia syndrome.